Learn more

KIRIN PHARMA KK

Overview
  • Total Patents
    73
About

KIRIN PHARMA KK has a total of 73 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are OSCIENT PHARMACEUTICALS CORP, ICOS CORP BOTHELL and LEUKOSITE INC.

Patent filings per year

Chart showing KIRIN PHARMA KKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tomizuka Kazuma 17
#2 Yoshida Hitoshi 12
#3 Osawa Tatsushi 11
#4 Miwa Atsushi 11
#5 Kubo Kazuo 11
#6 Fujiwara Yasunari 10
#7 Ishida Isao 8
#8 Kuroiwa Yoshimi 8
#9 Hasegawa Kazumasa 7
#10 Kataoka Shiro 7

Latest patents

Publication Filing date Title
WO2009111086A1 Transgenic non-human mammals with kappa light chain of xenogenous immunoglobulin
WO2009048769A2 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
US2008200654A1 Anti-A33 antibody
WO2008075796A1 Agent for promoting recovery from blood cell depletion
WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody
WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector
CN101448941A Agonistic antibody directed against human thrombopoietin receptor
US2009036369A1 Anti-tumor agents comprising r-spondins
MX2007011953A THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-Met AUTOPHOSPHORYLATION INHIBITING POTENCY.
AU2006229343A1 Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
EP1849863A1 Non-human chimeric animal and use thereof
EP2088141A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
KR20080090531A Anti-cd40 monoclonal antibody
US7317099B2 Polynucleotides encoding stem cell growth factor-like polypeptides
PL206627B1 Quinazoline derivative, its use and pharmaceutical composition